Tissue-agnostic cancer drug pipeline grows, despite doubts

Nature Reviews Drug Discovery 17, 227 (2018). doi:10.1038/nrd.2018.6 Author: Ken Garber The FDA could soon approve the first drug developed explicitly for a tissue-agnostic cancer indication, but biological complexity may limit this approach.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research